Melanie Gertz is an associate in the San Francisco office of Gibson, Dunn & Crutcher.  She currently practices in the firm’s Corporate Department.  Ms. Gertz’s practice is focused on capital markets transactions and mergers & acquisitions, and includes representation of clients in connection with corporate governance and Exchange Act reporting matters​.

Selected Transactions

• Initial Public Offering of 89bio, counsel to the issuer
• Initial Public Offering of Progenity, counsel to the Issuer
• Initial Public Offering of Shattuck Labs, counsel to the Issuer
• Initial Public Offering of StepStone Group, counsel to the Issuer
• Initial Public Offering of Petco Health and Wellness Company, counsel to the Issuer
• Initial Public Offering of Odonate Therapeutics, counsel to the issuer
• Sale of Glassdoor, Inc. to Recruit Holdings, counsel to Glassdoor
• Over $60 billion in public offerings of senior notes and preferred stock of Wells Fargo & Company and Wells Fargo Bank, N.A., counsel to the underwriters
• Over $20 billion in investment grade debt offerings for a large semiconductor company, counsel to the issuer
• At-the-market equity offering of California Water Service Group
• Follow-on equity offerings of 89bio, Progenity, Ultragenyx Pharmaceutical, Rocket Pharmaceuticals, Odonate Therapeutics, Heron Therapeutics, Rockwell Medical and Eledon Pharmaceuticals, counsel to the issuer

Ms. Gertz received her J.D. from the University of Michigan Law School in 2016, where she was the Managing Editor of the Michigan Business & Entrepreneurial Law Review.  While in law school, Ms. Gertz worked in the Transactional Lab and Clinic, advising large organizations around the country and small organizations in the Ann Arbor community on transactional matters.

She earned her B.A., magna cum laude, in Communications, Legal Institutions, Economics and Government, with a minor in French, from American University in 2013.

Ms. Gertz is admitted to practice law in the State of California.